diclofenac has been researched along with Cystic Fibrosis in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "60% diclofenac was released within 3 h and 80% tobramycin was released within 45 min." | 5.72 | Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles. ( Hosseini, M; Marasini, N; Sheikh, Z; Spicer, PT; Traini, D; Wong, CYJ; Xin Ong, H; Young, P, 2022) |
| "60% diclofenac was released within 3 h and 80% tobramycin was released within 45 min." | 1.72 | Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles. ( Hosseini, M; Marasini, N; Sheikh, Z; Spicer, PT; Traini, D; Wong, CYJ; Xin Ong, H; Young, P, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marasini, N | 1 |
| Sheikh, Z | 2 |
| Wong, CYJ | 1 |
| Hosseini, M | 1 |
| Spicer, PT | 1 |
| Young, P | 1 |
| Xin Ong, H | 1 |
| Traini, D | 2 |
| Gomes Dos Reis, L | 1 |
| Bradbury, P | 1 |
| Meneguzzo, G | 1 |
| Scalia, S | 1 |
| Young, PM | 1 |
| Ong, HX | 1 |
2 other studies available for diclofenac and Cystic Fibrosis
| Article | Year |
|---|---|
Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
Topics: Administration, Inhalation; Cystic Fibrosis; Diclofenac; Dry Powder Inhalers; Excipients; Humans; Pa | 2022 |
Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis.
Topics: Administration, Inhalation; Anti-Inflammatory Agents; Bronchodilator Agents; Cystic Fibrosis; Diclof | 2021 |